Content area

|
|

Indikationer og anvendelse af ekstrakorporal shockbølgeterapi

Forfatter(e)
Sune Møller Skov-Jeppesen1, 2, Ronja Niemann Lundrup1, 2, Peter Bill Juul Ladegaard1, Jonas Mortensen1, Mia Dahl Sørensen2, 3 & Lars Lund1, 2
1) Urinvejskirurgisk Afdeling, Odense Universitetshospital 2) Klinisk Institut, Syddansk Universitet 3) Afdeling for Klinisk Patologi, Odense Universitetshospital

Ugeskr Læger 2019;181:V07180514

Reference: 
Ugeskr Læger 2019;181:V07180514

Sune Møller Skov-Jeppesen, Ronja Niemann Lundrup, Peter Bill Juul Ladegaard, Jonas Mortensen, Mia Dahl Sørensen & Lars Lund:

Indications and application of extracorporeal shockwave therapy

Ugeskr Læger 2019;181:V07180514

Extracorporeal shockwave therapy (ESWT) is a novel treatment modality to stimulate tissue regeneration and anti-fibrosis. In this review, we summarise the use of ESWT for erectile dysfunction (ED), diabetic foot ulcers (DFU), Peyronie’s disease (PD), chronic kidney disease (CKD), and scleroderma. Several randomised clinical trials demonstrate the efficacy of ESWT for vasculogenic ED and DFU, and ESWT may also relieve pain in patients with PD. ESWT is still experimental for CKD and scleroderma. In general, ESWT is associated with few and mild adverse effects.

Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Anette Bygum | 19/05
10 kommentarer
af Hans-Iver G. F.-D Kley | 18/05
1 Kommentar
af Per Bonding | 17/05
1 Kommentar
af Jakob Ramlau | 15/05
1 Kommentar
af Svend Erik Heiselberg | 12/05
1 Kommentar